Nabriva Therapeutics LEAP 1 Phase 3 Trial Topline Results Conference Call

Nabriva Therapeutics LEAP 1 Phase 3 Trial Topline Results Conference Call

Monday September 18, 2017 8:30 AM EDT

Live Teleconference Information

Primary # -
Secondary # -
Passcode -
86032729